Chongqing PegBio Biotechnology Co., Ltd.
↗Chongqing, China
Chongqing PegBio Biotechnology (also known as Paijin Biopharm) is a high-tech biopharmaceutical company specializing in the research, development, and production of recombinant protein and peptide drugs. Founded in 2013, the company utilizes proprietary PEGylation and protein modification platforms to develop long-acting therapeutics for chronic and life-threatening diseases.
The company operates a hybrid business model, combining an internal innovative drug pipeline with CDMO (Contract Development and Manufacturing Organization) services. It has successfully developed and transferred several biosimilar projects, including insulin and GLP-1 analogs, to major pharmaceutical players like Huadong Medicine and Sihuan Pharmaceutical, generating significant non-dilutive revenue to fund its innovative oncology and GI programs.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M
Founded:2013
Ownership:private
Status:operating
FUNDING
Stage:Series A/Strategic
Total Raised:$30M+
Investors:Huadong Medicine (中美华东), China Grand Pharmaceutical, Local Government Funds
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3
Modalities:PEGylated peptides, Recombinant proteins, Biosimilars
Active Trials:4
Trial Phases:Phase 1: 2 | Phase 2: 1 | Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Chongqing Aimeidi Biotechnology Co., Ltd.
Key Partnerships:Huadong Medicine (Strategic investor and licensing partner), Sihuan Pharmaceutical (Project transfer partner)
COMPETITION
Position:Emerging
Competitors:Suzhou PegBio (Paige), Takeda (Gattex/Revestive), Innovent Biologics, Hengrui Medicine
LEADERSHIP
Key Executives:
Fan Kai - Founder & CEO
Scientific Founders:Fan Kai
Board Members:Fan Kai
LINKS
Website:pegbiocq.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Chongqing PegBio Biotechnology Co., Ltd.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.